Related Experiment Video

Updated: Aug 15, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K

The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development

Haiyun Yu1, Fei Guan1, Heather Miller2

  • 1Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.

Emerging Microbes & Infections
|December 30, 2022
PubMed

Insights

The SARS-CoV-2 nucleocapsid protein is crucial for COVID-19 pathogenesis and immunity. This review explores its potential for developing COVID-19 prevention strategies by examining its roles in inflammation and immune responses.

Area of Science:

  • Virology
  • Immunology
  • Pathogenesis

Background:

  • Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, poses significant global health and economic risks.
  • The SARS-CoV-2 nucleocapsid protein is essential for viral replication and assembly.
  • Emerging evidence highlights the nucleocapsid protein's multifaceted role in COVID-19 pathogenesis and the immune response.

Purpose of the Study:

  • To review the multi-functional roles of the SARS-CoV-2 nucleocapsid protein.
  • To explore its potential applications in COVID-19 prevention strategies.
  • To summarize its involvement in inflammation, cell death, and innate/adaptive antiviral immunity.

Main Methods:

  • Literature review and synthesis of existing research on SARS-CoV-2 nucleocapsid protein.
  • Analysis of the protein's functions in viral replication, assembly, and host immune responses.
  • Examination of the protein's impact on inflammation, cell death, and immunity.

Main Results:

  • The nucleocapsid protein significantly influences viral pathogenesis and host immune evasion.
  • It plays a critical role in modulating inflammatory responses and programmed cell death pathways.
  • The protein is implicated in both innate and adaptive antiviral immunity against SARS-CoV-2.

Conclusions:

  • The SARS-CoV-2 nucleocapsid protein is a key target for understanding COVID-19 pathogenesis.
  • Its diverse functions present opportunities for novel therapeutic and preventative strategies against SARS-CoV-2.
  • Further research into the nucleocapsid protein's immunomodulatory properties could lead to effective COVID-19 prevention.
Keywords:
SARS-CoV-2adapted immunitycell deathinflammationinnate immunitynucleocapsidvaccine

More Related Videos

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.9K
Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

558

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.4K
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
63.0K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
874
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Vaccinations01:51

Vaccinations

Overview
45.1K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
616